Liothyronine Sodium Accord (Liothyronine Sodium)

Liothyronine sodium is a synthetic form of the natural hormone triiodothyronine (T3). After oral absorption, it enters cells and binds to nuclear thyroid hormone receptors, triggering gene transcription that raises basal metabolic rate, enhances protein synthesis, and influences cardiovascular and nervous system activity, thereby compensating for deficient endogenous hormone.

The dose of Liothyronine Sodium Accord is individualized and determined by the prescribing clinician based on the patient’s age, weight, severity of thyroid deficiency, and response to therapy. Dosage adjustments are guided by regular monitoring of thyroid function tests and clinical assessment.

Safety data for liothyronine sodium in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Liothyronine Sodium Accord, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Liothyronine sodium provides active T3 hormone directly, leading to a faster onset of action compared with levothyroxine (T4), which must be converted to T3 in peripheral tissues. Some patients benefit from T3 supplementation when T4 alone does not achieve optimal symptom control, but dosing and monitoring differ between the two agents.

Liothyronine Sodium Accord should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Liothyronine Sodium Accord is taken orally, usually once daily or as directed by the prescriber. It should be swallowed with water, and patients are advised to follow any specific instructions regarding timing relative to meals or other medications.

Serious risks include cardiac arrhythmias such as atrial fibrillation, angina or myocardial infarction, severe hyperthyroid reactions (thyrotoxic crisis), bone loss leading to fractures, and rare allergic reactions. Patients with pre‑existing heart disease or osteoporosis require careful monitoring.

Liothyronine Sodium Accord should be avoided in patients with untreated adrenal insufficiency, uncontrolled cardiac disease, or known hypersensitivity to liothyronine or any excipients in the formulation. It is also contraindicated in individuals where thyroid hormone replacement is not indicated.